A surprising triple treatment completely clears hiv in newborn primates

sciencedaily - Researchers have found a striking new way to potentially eliminate HIV soon after infection using a one-time combination of three therapies. In newborn nonhuman primates treated within three days of exposure, the regimen—standard antiretroviral drugs, bro…

AI Summary: A preclinical study reports that a triple‑dose therapeutic regimen eradicated detectable HIV in newborn primates, offering proof‑of‑concept that very early, intensive intervention might prevent persistent infection. Translation to human infants will require careful clinical trials, ethical oversight and long follow‑up, but the findings mark a hopeful, if cautious, step toward functional cures.

#pharmaceuticals #publichealth #biotech #drugdevelopment #infanthealth #animalhealth #infectiousdisease #clinicaltrials

7 wks / sciencedaily

1 month / medicalxpress


Back to Top / Sat, August 15, 2026, 1:22 am / permalink 28795 / 2 stories in 7 wks /




Related Stories


Engineered 15‑strain biotherapeutic matches donor FMT for C. difficile / 3 months

One hepatitis B drug shows early functional cures in trial / 4 months

Dual Lassa–rabies vaccine phase 1 shows safety in humans / 3 months

Study finds MenB vaccine does not prevent gonorrhea in men / 2 months

Antiviral ensitrelvir dramatically cuts household COVID transmission risk / 4 months

Fridge‑free vaccine advances aim to cut massive vaccine wastage / 1 month

Experimental plague vaccine protects immune‑deficient mice from pneumonic plague / 2 months

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try FDA, Vaccine Safety, Clinical Trials, Government Policy and look for the RSS link.




↑

NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.